WILMINGTON, Del., Aug. 11 ParagonRx, a healthcare consulting leader in risk management and the appropriate use of drugs, is sponsoring a free Webinar-on-Demand created by the Drug Safety Executive Council which discusses risk management as a role of chief safety officers in healthcare companies.
The webinar can be accessed at ParagonRx's website, www.paragonrx.com/experience/webinars/.
"ParagonRx has historically been instrumental in the development of risk management strategies and of the implementation of FDA-required REMS -- or Risk Evaluation and Mitigation Strategies -- for pharmaceutical and biotech and products," says Jeffrey Fetterman, President and CEO, "and we are delighted to partner with the DSEC on this project." DSEC is a peer-to-peer organization for drug safety leaders in the medical arena.
ParagonRx is a Delaware-based company that works with pharmaceutical, biotech and medical devices companies to design and implement REMS and other risk management plans as well as better market under-utilized drugs.